INSIGHTS
Insights that cut through complexity
Six months after authorization, what do we know about Paxlovid?
See this article by RemedyOne EVP of clinical services Robert Louie as it originally appeared in Pharmaphorum. It has now…
How the pharmaceutical industry can turn the tide on mental health
May is Mental Health Awareness Month. RemedyOne president Ralph Pisano wrote this article for Fierce Healthcare about how the pharmaceutical…
New Developments in Macular Degeneration/Diabetic Eye Disease
Visual impairment can be a major health issue for older adults, ranging from a minor inconvenience to vision loss significantly…
Drug Innovation Continues Despite a World-Wide Pandemic
While much of the world was on pause during the COVID-19 pandemic, there are definite signs that even a pandemic…
Three pharmacy trends that will define 2022
See article as it originally appeared in MedCity News. The pharmaceutical industry made more headlines in 2021 than in any…
2022 Q1 RemedyOne Quarterly Pipeline Report
Download our 2022 Q1 Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
Menu
Like what you’re seeing?
Get more Insights sent to you.
